Comparable Outcomes Using A CMV-Matched or A Mismatched Donor for CMV Plus Patients Undergoing T-Replete Haplo-HSCT with PT-Cy for Acute Leukemia: A Study from IDWP and ALWP of the EBMT

Cesaro, S.Crocchiolo, R.Tridello, G.Knelange, N.Van Lint, M. T.Koc, Y.Ciceri, F.Gulbas, Z.Tischer, J.Afanasyev, B.Bruno, B.Castagna, L.Blaise, D.Mohty, M.Irrera, G.Diez-Martin, J. L.Pierelli, L.Pioltelli, P.Arat, M.Specchia, G.Fagioli, F.Ehninger, G.Aljurf, M.Carella, A. M.Mikulska, M.Nagler, A.Styczynski, J.Ozdogu, H.2023-05-252023-05-2520170268-3369http://hdl.handle.net/11727/9183enginfo:eu-repo/semantics/closedAccessComparable Outcomes Using A CMV-Matched or A Mismatched Donor for CMV Plus Patients Undergoing T-Replete Haplo-HSCT with PT-Cy for Acute Leukemia: A Study from IDWP and ALWP of the EBMTconferenceObject52000424355301108